Literature DB >> 14673947

Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.

Fen Wang1, Kerstin McKeehan, Chundong Yu, Michael Ittmann, Wallace L McKeehan.   

Abstract

BACKGROUND: Ectopic expression of fibroblast growth factor receptor 1 (FGFR1) tyrosine kinase in epithelial cells is associated with progression of prostate cancer. Ectopic expression by transfection of FGFR1 in premalignant epithelial cells from nonmalignant Dunning tumors accelerated time-dependent progression of epithelial cells to malignancy. This study was designed to test the effect of chronic androgen-dependent ectopic activity of FGFR1 in the normal adult mouse epithelium by gene targeting.
MATERIALS AND METHODS: Constitutively active FGFR1 (caFGFR1) was targeted to prostate epithelial cells using the androgen-dependent probasin (PB) promoter. Prostate tissues of three strains were characterized over a period of 2 years by HE staining, immunohistochemical analyses for cytokeratin and alpha-actin, and rate of androgen-induced regeneration after castration.
RESULTS: Relative to wildtype littermates, transgenic mice showed increased overall size, hyperplasia in epithelial, and, to a lesser extent, stromal compartments and nuclear atypia in epithelial cells of the prostate with increasing age. Androgen-induced regeneration after castration was enhanced at day 3 by two-fold in mice expressing ectopic caFGFR1.
CONCLUSIONS: The ectopic presence and chronic activation of FGFR1 in mouse prostate epithelial cells induces progressive prostate intraepithelial neoplasia. These results confirm results suggested by the transplantable Dunning tumor and cell culture models that, in contrast to homeostasis-promoting resident FGFR2, chronic ectopic FGFR1 kinase activity in the epithelium disrupts homeostasis between stroma and epithelium. Although insufficient alone, it may cooperate with other oncogenic changes to promote epithelial cells down the path to malignancy. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14673947     DOI: 10.1002/pros.10311

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.

Authors:  Teresa D Elo; Eeva M Valve; Jani A Seppänen; Heikki J Vuorikoski; Sari I Mäkelä; Matti Poutanen; Paula M Kujala; Pirkko L Härkönen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells.

Authors:  Masashi Kobayashi; Yanqing Huang; Chengliu Jin; Yongde Luo; Tetsuji Okamoto; Fen Wang; Wallace L McKeehan
Journal:  Prostate       Date:  2011-03-28       Impact factor: 4.104

Review 3.  Targeting fibroblast growth factor pathways in prostate cancer.

Authors:  Paul G Corn; Fen Wang; Wallace L McKeehan; Nora Navone
Journal:  Clin Cancer Res       Date:  2013-09-19       Impact factor: 12.531

Review 4.  Prostate Organogenesis.

Authors:  Jeffrey C Francis; Amanda Swain
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

Review 5.  From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer.

Authors:  Chuan Yu; Kevin Hu; Daniel Nguyen; Zhu A Wang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

Review 6.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

7.  Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients.

Authors:  J Liu; P You; G Chen; X Fu; X Zeng; C Wang; Y Huang; L An; X Wan; N Navone; C-L Wu; W L McKeehan; Z Zhang; W Zhong; F Wang
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

8.  Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.

Authors:  Michael Ittmann; Jiaoti Huang; Enrico Radaelli; Philip Martin; Sabina Signoretti; Ruth Sullivan; Brian W Simons; Jerrold M Ward; Brian D Robinson; Gerald C Chu; Massimo Loda; George Thomas; Alexander Borowsky; Robert D Cardiff
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

Review 9.  Fibroblast growth factors, old kids on the new block.

Authors:  Xiaokun Li; Cong Wang; Jian Xiao; Wallace L McKeehan; Fen Wang
Journal:  Semin Cell Dev Biol       Date:  2016-01-06       Impact factor: 7.727

10.  FGFR1 is essential for prostate cancer progression and metastasis.

Authors:  Feng Yang; Yongyou Zhang; Steven J Ressler; Michael M Ittmann; Gustavo E Ayala; Truong D Dang; Fen Wang; David R Rowley
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.